Resources for Parents of Children with KCNT1 Epilepsy - KCNT1 Epilepsy Foundation

Information for parents whose child was recently diagnosed with kcnt1 - related epilepsy

We want to ensure that parents have a voice.

parents & caregivers

KCNT1-related Epilepsy Diagnosis

Finding out that your child has a KCNT1 gene mutation is a troubling emotional experience, and it can be overwhelming for a parent trying to understand all the new information. All children are different and can vary widely in their symptoms. We aim to provide families with information to help you get the best care possible from the very beginning, because important decisions are made soon after diagnosis.  

We cannot provide medical advice but can suggest what topics to discuss with your healthcare providers. We have a network of parents who have children living with KCNT1 who support one another. Please reach out to us if you need help or have any questions.    


What is KCNT1

KCNT1 is a channel that affects the flow of electricity in the brain and sometimes in the heart. This channel is found throughout the body, and mutations in KCNT1 result in increased electrical flow through the potassium channels. This primarily results in problems in electric electrical activity in the brain, which can cause seizures. KCNT1-related epilepsy syndromes: 1) early onset seizures, either epilepsy of infancy with migrating focal seizures EIMFS, also known as migrating partial seizures of infancy MMPSI, or 2) it can cause an epileptic encephalopathy (EE). There is also 3) a later onset form of KCNT1 related epilepsy which is often known as Sleep-related Hypermotor Epilepsy, formerly known as autosomal dominant nocturnal frontal lobe epilepsy ADNFLE.. KCNT1 is also expressed in the heart and in the blood vessels coming out of the heart. And this can sometimes result in cardiac arrhythmias or inabnormal blood vessels that go from the heart to the lungs. Those are called aorta, pulmonary collaterals. Reports have identified children who exhibit symptoms of both, while some people carry a gene mutation but have no seizures. Other syndromes associated with KCNT1 can include Ohtahara and West syndromes.

Some people are carriers and have no symptoms. If you have a genetic test with KCNT1 you should speak with a genetic counselor.


EIMFS or MMPSI– Onset Before 6 Months

Seizures often begin before 6 months of age and increase in frequency and severity, negatively impacting neurodevelopment and often resulting in regression and severe developmental disabilities. Other names: Epilepsy of Infancy with Migrating Focal Seizures (EIMFS), Early Infantile Epileptic Encephalopathy, MMPSI or Migrating Partial Epilepsy of Infancy. Seizures may be difficult to detect but the child may get hiccups, stop breathing, turn blue, or sweat moderately. Seizures in EIMFS are resistant to medication and can progress to nearly continuous by age six to nine months. This can result in prolonged seizures or status epilepticus.

Sleep-Related Hypermotor Epilepsy (SHE) (formally known as ADNFLE) – Onset After 6 Months

The KCNT1 mutation can cause clusters of nocturnal seizures that vary from simple arousals to very physical thrashing movements. These seizures happen during sleep and can bemistaken as night terrors. This phenotype is referred to as Sleep-Related Hypermotor Epilepsy (SHE) , formerly known as Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE) seizures typically start later than EIMFS. Download clinician handout here.

Diagnosis

The diagnosis is established in a patient with intractable epilepsy and with identification of a heterozygous pathogenic variant in KCNT1 through genetic testing from a certified lab. The patients with EIMFS/MMPSI syndrome are most often de novo KCNT1 mutations, and most with SHE/ANDFLE are inherited from one parent. Several genetic testing companies include the KCNT1 gene in their epilepsy panels but when possible, we recommend whole genome or whole Exome testing of the affected child and the parents.. It is preferred that genetic tests are certified by the American Board of Medical Genetics and Genomics.

Treatment

Treatment for KCNT1-related epilepsy initially focuses on reducing or stopping the number of seizures. Unfortunately many traditional anti-convulsant medications don't work very well so you must work with your physician to try different options. The types of seizures experienced by these children are so variable that surgical intervention is not an option although some patients have vagus nerve stimulating (VNS) device surgically implanted with limited success. Many parents report that a ketogenic diet is one of the most effective ways to reduce seizures followed by Phenobarbital, Topamax Tegretol. Quinidine has been used as an off-label anticonvulsant with success in some patients, but careful monitoring is necessary due to possible negative effects on the heart. Some parents report some improvement with cannabidiol but there is not sufficient research in this area. In addition to reducing seizures, treatments focus on addressing symptoms that are often associated with low muscle tone and sedation from the medications. These can create issues with feeding and swallowing, gastrointestinal difficulties, constipation, urinary tract issues. Often parents are faced with a decision ofwhether to supplement their child's nutrients through the placement of a temporary feeding tube, or amore permanent G-tube. Some children have issues with their heart and lungs, particularly the development of potentially dangerous blood vessels called major aortic and pulmonary collaterals that must be carefully monitored to ensure they do not rupture. In some cases of pulmonary collaterals embolization is recommended. Breathing issues and managing oral secretions can also be an issue. Sleep apnea and seizures during sleep require monitoring with different devices and alarms. Parents also must consider special beds, supportive chairs, and standing walkers to aid the development of bones and muscles. Creative parents and therapists have adapted toys, tables, and devices to find ways to provide entertainment for their children as well as a means of stimulating cognitive and visual development. Caring for the special needs of your child requires a great deal of effort but having a coordinated medical team and supportive community can help parents affectively manage their child's care. More treatment guidelines are available at the link below.


 

Downloadable KCNT1 Information Sheets

If you don't see your preferred language, download the English version and translate it with your translator of choice.

“Celebrate the little things always,
to us those are big things!” 

Andrew-West.jpeg

TIPS FOR FAMILIES WHO WERE RECENTLY DIAGNOSED

  1. Take a deep breath! 

  2. Find a pediatric epileptologist (epilepsy specialist)  

  3. Obtain a copy of your genetic reports 

  4. Request a heart check-up with EKG

  5. Start a folder to track medications, symptoms, seizures (number and duration) 

  6. Develop a seizure action plan with your epileptologist (Epilepsy Foundation

  7. Understand all medications and proper use of rescue drugs, ensuring you have plenty on hand. 

  8. Understand risk of SUDEP (ask your epileptologist about whether a monitor could be useful) 

  9. Apply for assistance - Medicaid programs can help with costs of care 

  10. Get referrals for support services such as physical/occupational/vision therapy and equipment (shower chair, stander) 

  11. Discuss the ketogenic diet as an option for seizure management with your doctor 

  12. Talk to your family and other children about the condition 

  13. Find a parent support group (there are several Facebook groups for KCNT1 specifically as well as epilepsy more generally) 

  14. Create a seizure diary through the Epilepsy Foundation   

  15. Start a Caregiver Respite notebook from Child Neurology Foundation 

  16. Enroll in the patient registry here

 

There are many resources online and in your local community.

We have curated links on our Resources page. 

 
 

Types of Healthcare Specialists You May See In Addition to Your Epileptologist 

  • Developmental Pediatrician

  • ENT – Ear Nose and Throat 

  • Epileptologist 

  • Endocrinologist 

  • Gastroenterologist 

  • Geneticist 

  • Occupational, Speech, Physical and Vision Therapist 

  • Ophthalmologist 

  • Orthopedist 

  • Pediatric Neurologist 

  • Palliative Care 

  • Physiatrist 

  • Psychologist 

  • Pulmonologist 

  • Urologist 

    For more information about other specialists click here

Associated Medical Conditions 

  • Autism spectrum disorder 

  • Cerebral Palsy (spasticity, hypotonia) 

  • Cardiac and pulmonary defects 

  • Cortical Vision Impairment 

  • GI Dysfunction (Reflux & constipation) 

  • Global Developmental Delays 

  • Intellectual Disability (like autism and Fragile X) 

  • Movement Disorders (ataxia, dystonia) 

  • Neuropathic Pain 

  • Sleep Disorders 

  • Speech and Language Impairments 

  • Sudden Infant Death Syndrome Risk 

  • Urology problems (infections & urinary retention) 

 

contribute to research & Enroll in KCNT1 Community STUDIES

Families have a very important role to play in the KCNT1 community. We highly encourage you to sign up on our Family Contact list and take part in surveys for research. Researchers will use the data that families share to get firsthand information about the symptom our children experience, and how they respond to various treatments.  By joining our family network you will be notified to take part in any clinical trials that become available. For more ways to help, see our Get Involved page.

 

Natural History Study

An ongoing digital natural history study is being conducted through the Ciitizen platform. It contains a robust database with detailed clinical data, genetic, and developmental data. Parents can sign up here. To apply for access to this data contact info@kcnt1epilepsy.org

Biosample Repository

A biobank houses human biological materials such as blood, DNA, and tissues linked to detailed clinical data in the Natural History database. This tissue and their associated clinical data will allow researchers to search for clues to understand why KCNT1 mutations can differ from person to person. The tissue can also be turned into cell lines that researchers and drug developers can use to better understand the disease and test out new therapies before moving on to clinical trials. We currently have a biobank through CombinedBrain. If you would are are researcher and would like access to our specimens email info@kcnt1epilepsy.org Parents who wish to provide blood or other bio specimens should click on Participate and fill out the form.

Search the Site